NEW ProSelect Listing: Ionis Pharmaceuticals (IONS)
IONS falls into the category of a beaten down stock with positive projected earnings. Yahoo finance estimates that earnings will growth by +68% next year and +49% (avg) over the next 5 years. ... (to read the remainder of this article, please log in below.)
The resource you have requested is available only to current members.IONS falls into the category of a beaten down stock with positive projected earnings. Yahoo finance estimates that earnings will growth by +68% next year and +49% (avg) over the next 5 years. ... (to read the remainder of this article, please log in below.)
|